Henan Lingrui Pharmaceutial Co., Ltd. Class ASSE: 600285

"HENAN LINGRUI PHARMACEUTICAL CO., LTD."Semi-annual Report for 2026

Aug 12, 2026 · Issued by Henan Lingrui Pharmaceutial Co., Ltd. Class A via Shanghai Stock Exchange

Semi-annual Report for 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Henan Lingrui Pharmaceutial Co., Ltd. Class A

"HENAN LINGRUI PHARMACEUTICAL CO., LTD."Announcement on Release of Pledge and Re-pledge of Certain Shares Held by Major ShareholderAug 5
"HENAN LINGRUI PHARMACEUTICAL CO., LTD."Announcement on Inclusion of Products of the Company and Its Subsidiaries in the "National Essential Medicines List (2026 Edition)"Jul 11
Announcement on Obtaining Notice of Approval for Drug Supplementary ApplicationJun 24
Announcement on Resolutions of the 2nd Meeting of the 10th Board of DirectorsJun 12

All Henan Lingrui Pharmaceutial Co., Ltd. Class A news releases